Compare Aurora Cannabis Inc (ACB) vs Zoom Video Communications, Inc. (ZM) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Zoom Communications (ZM) trades at $85.68, down 1.68% on the day, with a bearish technical outlook despite strong fundamentals. The stock shows robust profitability with 77.4% gross margins and 42% net income margin, while trading at attractive valuation multiples (P/E 12.5x, P/S 5.2x). Recent Q1 2026 earnings beat expectations, and the company continues AI-driven growth through acquisitions like Common Room and new product launches.

ZM presents a compelling value opportunity with significant upside to the $118.79 consensus price target, though technical weakness and competitive pressures from Microsoft and Google remain headwinds. The company's strong cash position ($7.7B) and strategic Anthropic investment provide additional upside catalysts, making it attractive for patient investors despite near-term bearish technical signals.